In order to provide complete functionality, this web site needs your explicit consent to store browser cookies. If you don't allow cookies, you may not be able to use certain features of the web site including but not limited to: log in, buy products, see personalized content, switch between site cultures. It is recommended that you allow all cookies.

National Prescribing Indicators

National Prescribing Indicators for 2018-2019

The National Prescribing Indicators for 2018–2019 have been prepared by a multiprofessional collaborative group, with support from the All Wales Prescribing Advisory Group (AWPAG) and the All Wales Therapeutics and Toxicology Centre (AWTTC), and subsequently endorsed by the All Wales Medicines Strategy Group (AWMSG) at their February 2018 meeting.

National Prescribing Indicators (NPIs) are developed annually with the aim of  promoting rational prescribing. The indicators are evidence-based and are designed to be clear, easily understood and allow health boards, primary care clusters, GP practices and prescribers to compare current prescribing practice against an agreed standard of quality.

The NPIs for 2018–2019 comprise twelve measures; each of which has been organised into one of three categories with a focus on safety, stewardship or efficiency. The new or updated NPIs for 2018–2019 include
:
  • Prescribing Safety Indicators have been added (a series of measures aimed at identifying patients at high risk of adverse drug reactions and medicines-related harm in primary care, which will be monitored by Audit+);
  • Co-amoxiclav, cephalosporins and fluoroquinolones have been combined, with the addition of clindamycin, to create the 4C NPI;
  • Colorectal surgical prophylaxis will now monitor the proportion of elective colorectal patients receiving a single dose antimicrobial for surgical prophylaxis;
  • Yellow Card reporting NPI will now include those submitted in secondary care and by the public.
The National Prescribing Indicators document provides detailed background information and evidence to support the aims of each indicator, and is available here: National Prescribing Indicators 2018–2019.

In addition to the main NPI document, a concise summary of the NPIs has also been published, entitled Supporting Information for Prescribers. The document contains a brief overview of each NPI, including purpose, units of measure, brief rationale and prescribing points, and links to useful resources: National Prescribing Indicators 2018–2019: Supporting Information for Prescribers.

A slide set has also been developed for local adaptation: National Prescribing Indicators 2018–2019 Slide Set.


National Prescribing Indicators 2017–2018: Analysis of Prescribing Data to March 2018
 
The National Prescribing Indicators 2017–2018: Analysis of Prescribing Data to March 2018 document has been prepared by the Welsh Analytical Prescribing Support Unit and can be accessed at
 
https://www.awttc.org/national-prescribing-indicators-2017-2018-analysis-prescribing-data-march-2018